Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bove, Riley ^a,b   Secor, Elizabeth ^a   Healy, Brian C ^a   Musallam, Alexander ^a   Vaughan, Timothy ^c   Glanz, Bonnie I ^a   Greeke, Emily ^a   Weiner, Howard L ^a,b   Chitnis, Tanuja ^a,b   Wicks, Paul ^c   De Jager, Philip L ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PATIENTSLIKEME INC   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AMBULATION INDEX; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS RATING SCALE; ONLINE SYSTEM; RATING SCALE; SAMPLE SIZE; SELF REPORT; SEX DIFFERENCE; TIMED 25 FOOT WALK; VALIDATION PROCESS;

BODY MASS INDEX; DEMOGRAPHY; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; INTERNET; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX; SOFTWARE; WALKING;

EID: 84875188727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059707     Document Type: Article

References (40)

1. Wicks P, Vaughan TE, Massagli MP, (2012) The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community. Health and quality of life outcomes 10: 70.
2. Schwartz CE, Sprangers MA, Oort FJ, Ahmed S, Bode R, et al. (2011) Response shift in patients with multiple sclerosis: an application of three statistical techniques. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation 20: 1561-1572.
3. Doward LC, McKenna SP, Meads DM, Twiss J, Eckert BJ, (2009) The development of patient-reported outcome indices for multiple sclerosis (PRIMUS). Multiple sclerosis 15: 1092-1102.
4. Twiss J, Doward LC, McKenna SP, Eckert B, (2010) Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS). Health and quality of life outcomes 8: 117.
5. Munger KL, Chitnis T, Ascherio A, (2009) Body size and risk of MS in two cohorts of US women. Neurology 73: 1543-1550.
6. Hedstrom AK, Olsson T, Alfredsson L (2012) High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Multiple sclerosis.
7. Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T, (2011) Association between comorbidity and clinical characteristics of MS. Acta neurologica Scandinavica 124: 135-141.
8. Salter AR, Marrie RA, Tyry T, Cofield SS, Fox R,et al. Is weight associated with disability in a 6-year period as assessed in the NARCOMS Registry?; 2011; Amsterdam.
9. Brownstein CA, Brownstein JS, Williams DS, 3rd, Wicks P, Heywood JA (2009) The power of social networking in medicine. Nature biotechnology 27: 888-890.
10. Wicks P, Keininger DL, Massagli MP, la Loge CD, Brownstein C, et al. (2011) Perceived benefits of sharing health data between people with epilepsy on an online platform. Epilepsy & behavior: E&B.
11. Wicks P, Vaughan TE, Massagli MP, Heywood J, (2011) Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nature biotechnology 29: 411-414.
12. Wicks P, Frost J, (2008) ALS patients request more information about cognitive symptoms. European journal of neurology: the official journal of the European Federation of Neurological Societies 15: 497-500.
13. Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, et al. (2011) Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry 82: 853-854.
14. Wicks P, Massagli M, Kulkarni A, Dastani H, (2011) Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). Journal of medical Internet research 13: e12.
15. Gholipour T, Healy B, Baruch NF, Weiner HL, Chitnis T, (2011) Demographic and clinical characteristics of malignant multiple sclerosis. Neurology 76: 1996-2001.
16. Kurtzke J, (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 1444-1452.
17. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, et al. (1983) Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. The New England journal of medicine 308: 173-180.
18. Fischer JS, Rudick RA, Cutter GR, Reingold SC, (1999) The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Multiple sclerosis 5: 244-250.
19. Marrie RA, Goldman M, (2007) Validity of performance scales for disability assessment in multiple sclerosis. Multiple sclerosis 13: 1176-1182.
20. Mathew M, Morrow JR, Frierson GM, Bain TM, (2011) Assessing digital literacy in web-based physical activity surveillance: the WIN study. American journal of health promotion: AJHP 26: 90-95.
21. Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T, (2007) Validation of the NARCOMS registry: diagnosis. Multiple sclerosis 13: 770-775.
22. Buchanan RJ, Chakravorty BJ, Tyry T, Hatcher W, Vollmer T, (2009) Age-related comparisons of people with multiple sclerosis: demographic, disease, and treatment characteristics. NeuroRehabilitation 25: 271-278.
23. Gardener H, Munger KL, Chitnis T, Michels KB, Spiegelman D, et al. (2009) Prenatal and perinatal factors and risk of multiple sclerosis. Epidemiology 20: 611-618.
24. Nortvedt MW, Riise T, Maeland JG, (2005) Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 26: 334-339.
25. Ghadirian P, Jain M, Ducic S, Shatenstein B, Morisset R, (1998) Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. International journal of epidemiology 27: 845-852.
26. Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, et al. (2009) Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 72: 117-124.
27. Khurana SR, Bamer AM, Turner AP, Wadhwani RV, Bowen JD, et al. (2009) The prevalence of overweight and obesity in veterans with multiple sclerosis. American journal of physical medicine & rehabilitation/Association of Academic Physiatrists 88: 83-91.
28. Gorber SC, Tremblay M, Moher D, Gorber B, (2007) A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obesity reviews: an official journal of the International Association for the Study of Obesity 8: 307-326.
29. Musabak U, Demirkaya S, Genc G, Ilikci RS, Odabasi Z, (2011) Serum adiponectin, TNF-alpha, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens. Neuroimmunomodulation 18: 57-66.
30. Matarese G, Carrieri PB, Montella S, De Rosa V, La Cava A, (2010) Leptin as a metabolic link to multiple sclerosis. Nature reviews Neurology 6: 455-461.
31. Hietaharju A, Kuusisto H, Nieminen R, Vuolteenaho K, Elovaara I, et al. (2010) Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study. European journal of neurology: the official journal of the European Federation of Neurological Societies 17: 332-334.
32. Kraszula L, Jasinska A, Eusebio MO, Kuna P, Glabinski A, et al. (2012) Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis. Neurologia i neurochirurgia polska 46: 22-28.
33. Lucas RM, Hughes AM, Lay ML, Ponsonby AL, Dwyer DE, et al. (2011) Epstein-Barr virus and multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry 82: 1142-1148.
34. Consortium IMSG, (2011) Genome-wide association study of severity in multiple sclerosis. Genes and immunity 12: 615-625.
35. Wingerchuk DM, (2012) Smoking: effects on multiple sclerosis susceptibility and disease progression. Therapeutic advances in neurological disorders 5: 13-22.
36. Healy BC, Ali EN, Guttmann CR, Chitnis T, Glanz BI, et al. (2009) Smoking and disease progression in multiple sclerosis. Archives of neurology 66: 858-864.
37. Munger KL, Ascherio A, (2011) Prevention and treatment of MS: studying the effects of vitamin D. Multiple sclerosis. 17: 1405-1411.
38. Turer CB, Lin H, Flores G, (2013) Prevalence of Vitamin D Deficiency Among Overweight and Obese US Children. Pediatrics 131: e152-161.
39. Buchanan EA, Hvizdak EE, (2009) Online survey tools: ethical and methodological concerns of human research ethics committees. Journal of empirical research on human research ethics: JERHRE 4: 37-48.
40. Cantrell MA, Lupinacci P, (2007) Methodological issues in online data collection. Journal of advanced nursing 60: 544-549.